Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP416849.RAbAOQmialEVMQ3R0jB1Tv7YTjggPUBBEa1YktV9CAF9Q130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP416849.RAbAOQmialEVMQ3R0jB1Tv7YTjggPUBBEa1YktV9CAF9Q130_assertion type Assertion NP416849.RAbAOQmialEVMQ3R0jB1Tv7YTjggPUBBEa1YktV9CAF9Q130_head.
- NP416849.RAbAOQmialEVMQ3R0jB1Tv7YTjggPUBBEa1YktV9CAF9Q130_assertion description "[Oncofetal fibronectin (onfFN) and galectin-3 (Gale-3) have been proposed as possible tools for the preoperative diagnosis of thyroid carcinomas, based on the finding that the expression of both onfFN and Gale-3 are significantly increased in papillary and anaplastic carcinomas, compared to normal thyroid tissues and follicular adenomas.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP416849.RAbAOQmialEVMQ3R0jB1Tv7YTjggPUBBEa1YktV9CAF9Q130_provenance.
- NP416849.RAbAOQmialEVMQ3R0jB1Tv7YTjggPUBBEa1YktV9CAF9Q130_assertion evidence source_evidence_literature NP416849.RAbAOQmialEVMQ3R0jB1Tv7YTjggPUBBEa1YktV9CAF9Q130_provenance.
- NP416849.RAbAOQmialEVMQ3R0jB1Tv7YTjggPUBBEa1YktV9CAF9Q130_assertion SIO_000772 14558920 NP416849.RAbAOQmialEVMQ3R0jB1Tv7YTjggPUBBEa1YktV9CAF9Q130_provenance.
- NP416849.RAbAOQmialEVMQ3R0jB1Tv7YTjggPUBBEa1YktV9CAF9Q130_assertion wasDerivedFrom befree-2016 NP416849.RAbAOQmialEVMQ3R0jB1Tv7YTjggPUBBEa1YktV9CAF9Q130_provenance.
- NP416849.RAbAOQmialEVMQ3R0jB1Tv7YTjggPUBBEa1YktV9CAF9Q130_assertion wasGeneratedBy ECO_0000203 NP416849.RAbAOQmialEVMQ3R0jB1Tv7YTjggPUBBEa1YktV9CAF9Q130_provenance.